Four senior CDC officials resigned in recent days, citing growing political interference in the agency’s scientific work.

Hysterectomy and hormone therapy produce similar survival outcomes in patients with early-stage endometrial cancer if they are younger than 40 years of age but not if they are 40-49 years of age.

Real-world data “confirm MammaPrint’s utility in identifying patients with low-risk cancers who can safely forego chemotherapy,” the researchers wrote.

The updated vaccine is expected to be available in the coming days. The US Food and Drug Administration (FDA) has approved the Comirnaty 2025-2026 COVID-19 vaccine formulation, which targets the LP.8.

The US Food and Drug Administration (FDA) has approved the 2025-2026 formulations of Moderna’s COVID-19 vaccines, Spikevax and mNexspike. These updated mRNA vaccines target the LP.8.1 variant of ...

Clinical and preclinical data have shown that the JN.1-targeted vaccine induces immunity across currently circulating JN.1 lineage strains, according to Novavax.

These results highlight the need to revisit current occupational health practices, particularly regarding radiation safety protocols in female healthcare workers,” the researchers wrote.

The prognostic value of early on-treatment weight loss was independent of prognostic factors previously identified for platinum-based chemotherapy, such as age, baseline albumin, renal function, and ...

Patients are missing opportunities for genetic testing and surgery that could prevent high-grade serous cancer, a study suggests.

The researchers concluded that active surveillance “is a durable long-term management strategy ..., particularly in older individuals.” ...

The FDA has granted breakthrough therapy designation to rinatabart sesutecan for the treatment of adults with advanced endometrial cancer.

Patients taking GLP-1 receptor agonists had a lower risk of cancer overall as well as lower risks of certain cancers.